
    
      This multicenter study consists of a Screening Visit (3 to 14 days prior to randomization); 4
      multiple-dose (7-day) Treatment Periods, each consisting of a 2-night/3-day inpatient stay
      (Day 6 to Day 8); and a Final Visit. A washout period of at least 21 days will occur between
      each Treatment Period. The Final/ Early Termination Visit will occur 6-8 days following the
      last Treatment Period or upon early discharge from the study.
    
  